ESC Professional Premium Access

Hypertrophic cardiomyopathy: not so rare, but not so easy

Event: ESC Congress 2022
Topic: Hypertrophic Cardiomyopathy
Session type: Abstract Sessions
Date: 29 August 2022
Time: 15:30 - 16:20

Congress Session

5 presentations in this session

Metoprolol improves left ventricular longitudinal function at rest and during exercise in obstructive hypertrophic cardiomyopathy

Speaker: Mrs A. Dybro (Aarhus, DK)

Mavacamten induces a clinical, hemodynamic, and biomarker response beyond the primary endpoint in EXPLORER-HCM: results from a post hoc machine learning analysis

Speaker: Doctor I. Olivotto (Florence, IT)

Prevalence and clinical correlates of clinical red flags for rare diseases in consecutive patients presenting with HCM phenotype

Speaker: Doctor N. Maurizi (Florence, IT)

Temporal trends, characteristics and comorbidities of patients with hypertrophic cardiomyopathy in denmark from 2005-2018: A nationwide cohort study.

Speaker: Doctor C. Zoerner (Copenhagen, DK)

Representativeness of EXPLORER-HCM trial and prevalence of eligibility criteria for Mavacamten in a nationwide cohort

Speaker: Doctor M. Brandao (Vila Nova de Gaia, PT)

5 speakers from this session

Mrs Anne Dybro

Skejby University Hospital, Aarhus (Denmark)
0 follower

Doctor Iacopo Olivotto

Careggi University Hospital (AOUC), Florence (Italy)
12 presentations

Doctor Niccolo' Maurizi

University of Florence, Florence (Italy)
1 presentation
0 follower

Doctor Christopher Ryan Zoerner

Herlev and Gentofte Hospital, Copenhagen (Denmark)
0 follower

Doctor Mariana Brandao

Hospital Center of Vila Nova de Gaia/Espinho, Vila Nova de Gaia (Portugal)
4 presentations
1 follower

This platform is supported by

logo Novo Nordisk